Incyte Price To Sales Ratio from 2010 to 2024

INCY Stock  USD 53.76  0.67  1.26%   
Incyte Price To Sales Ratio yearly trend continues to be fairly stable with very little volatility. Price To Sales Ratio will likely drop to 3.61 in 2024. Price To Sales Ratio is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. View All Fundamentals
 
Price To Sales Ratio  
First Reported
2010-12-31
Previous Quarter
3.7994956
Current Value
3.61
Quarterly Volatility
47.05114516
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Incyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incyte main balance sheet or income statement drivers, such as Depreciation And Amortization of 86.8 M, Interest Expense of 2.4 M or Total Revenue of 3.9 B, as well as many exotic indicators such as Price To Sales Ratio of 3.61, Dividend Yield of 0.0 or PTB Ratio of 2.84. Incyte financial statements analysis is a perfect complement when working with Incyte Valuation or Volatility modules.
  
This module can also supplement Incyte's financial leverage analysis and stock options assessment as well as various Incyte Technical models . Check out the analysis of Incyte Correlation against competitors.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Latest Incyte's Price To Sales Ratio Growth Pattern

Below is the plot of the Price To Sales Ratio of Incyte over the last few years. Price to Sales Ratio is figured by comparing Incyte stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Incyte sales, a figure that is much harder to manipulate than other Incyte multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. It is a valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period. Incyte's Price To Sales Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incyte's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 3.27 X10 Years Trend
Slightly volatile
   Price To Sales Ratio   
       Timeline  

Incyte Price To Sales Ratio Regression Statistics

Arithmetic Mean24.04
Geometric Mean11.89
Coefficient Of Variation195.68
Mean Deviation22.62
Median8.69
Standard Deviation47.05
Sample Variance2,214
Range188
R-Value(0.54)
Mean Square Error1,696
R-Squared0.29
Significance0.04
Slope(5.65)
Total Sum of Squares30,993

Incyte Price To Sales Ratio History

2024 3.61
2023 3.8
2022 5.25
2021 5.42
2020 7.11
2019 8.69
2018 7.18

About Incyte Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Incyte income statement, its balance sheet, and the statement of cash flows. Incyte investors use historical funamental indicators, such as Incyte's Price To Sales Ratio, to determine how well the company is positioned to perform in the future. Although Incyte investors may use each financial statement separately, they are all related. The changes in Incyte's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Incyte's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Incyte Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Incyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price To Sales Ratio 3.80  3.61 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Incyte offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Incyte's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Incyte Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Incyte Stock:
Check out the analysis of Incyte Correlation against competitors.
For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.
Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Incyte Stock analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
CEOs Directory
Screen CEOs from public companies around the world
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
6.705
Earnings Share
3.3
Revenue Per Share
16.82
Quarterly Revenue Growth
0.089
Return On Assets
0.0689
The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.